Delivery Order SPE2DB22D3501-SPE2DB25FUE83
Award Date
1/17/25
Potential Completion Date
1/21/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $22,522.21 and an ultimate completion date of September 4, 2024. It is a firm fixed price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Gadavist product to support the medical needs of military treatment facilities and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is for the delivery of Gadavist, a pharmaceutical product, with a ceiling value of $2,330.40 and a performance period through April 8, 2024.
Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $7,430.26 and an ultimate completion date of June 17, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order under an Indefinite Delivery Contract (IDC) it holds with the DLA,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Gadavist 1 mmol/ml bulk vials (30 ml) and has a ceiling value of $1,711.35. The delivery order is part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA, which has a potential value of $999,999,999.00 through December 31, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Gadavist 10 mmol/10 ml vials. The contract has a firm fixed price of $2,194.40 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Gadavist 10 mL vials, a specialty pharmaceutical product. The contract has a firm fixed price of $2,239.12 and a period of performance through October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as larger Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.81 firm fixed-price delivery order is for the supply of Gadavist, a medical imaging agent, with a period of performance through November 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,165.20, is for the delivery of Gadavist, a pharmaceutical product used for medical imaging. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Gadavist 10 mmol/10 ml vials. The $4,729.46 order has a completion date of January 30, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...